Cardona-Mendoza, Andrés FelipeRojas Puentes, LeonardoWills, BeatrizRuíz-Patiño, AlejandroAbril, Lina AlejandraJiménez, EncarnaciónUseche, NicolásBermúdez, SoniaMejia, Juan AlbertoRamón, Juan FernandoCarranza Isaza, HernánVargas, CésarOtero, JorgeArchila, PilarRodríguez, JaimeBehaine, JoséGonzález, DanielJacobo, JuanCifuentes, HéctorFeo, OscarPenagos, PedroPineda, DavidRicaurte, Luisa MaríaPino, Luis EduardoVargas, Carlos AndrésMárquez, JoanaMantilla, MonicaOrtiz, Leon D.Balaña, CarmeRosell, RafaelZatarain-Barrón, Zyanya LuciaArrieta, OscarHakim, Fernando2020-03-092020-03-0920191699-048Xhttps://hdl.handle.net/20.500.12495/2018application/pdfengA comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastomaarticleNeoplasias neuroepitelialesAnticuerpos monoclonalesImpresión molecularGlioblastomaSecond-line therapyBevacizumabMolecular expression classifcationhttps://doi.org/10.1007/s12094-019-02066-2instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coA comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastomaAcceso cerradoinfo:eu-repo/semantics/openAccesshttps://purl.org/coar/access_right/c_abf612019